{Reference Type}: Journal Article
{Title}: Rapid depletion of "catch-and-release" anti-ASGR1 antibody in vivo.
{Author}: Devanaboyina SC;Li P;LaGory EL;Poon-Andersen C;Cook KD;Soto M;Wang Z;Dang K;Uyeda C;Case RB;Thomas VA;Primack R;Ponce M;Di M;Ouyang B;Kaner J;Lam SK;Mostafavi M;
{Journal}: MAbs
{Volume}: 16
{Issue}: 1
{Year}: 2024 Jan-Dec
{Factor}: 6.44
{DOI}: 10.1080/19420862.2024.2383013
{Abstract}: Targeting antigens with antibodies exhibiting pH/Ca2+-dependent binding against an antigen is an attractive strategy to mitigate target-mediated disposition and antigen buffering. Studies have reported improved serum exposure of antibodies exhibiting pH/Ca2+-binding against membrane-bound receptors. Asialoglycoprotein receptor 1 (ASGR1) is a membrane-bound receptor primarily localized in hepatocytes. With a high expression level of approximately one million receptors per cell, high turnover, and rapid recycling, targeting this receptor with a conventional antibody is a challenge. In this study, we identified an antibody exhibiting pH/Ca2+-dependent binding to ASGR1 and generated antibody variants with increased binding to neonatal crystallizable fragment receptor (FcRn). Serum exposures of the generated anti-ASGR1 antibodies were analyzed in transgenic mice expressing human FcRn. Contrary to published reports of increased serum exposure of pH/Ca2+-dependent antibodies, the pH/Ca2+-dependent anti-ASGR1 antibody had rapid serum clearance in comparison to a conventional anti-ASGR1 antibody. We conducted sub-cellular trafficking studies of the anti-ASGR1 antibodies along with receptor quantification analysis for mechanistic understanding of the rapid serum clearance of pH/Ca2+-dependent anti-ASGR1 antibody. The findings from our study provide valuable insights in identifying the antigens, especially membrane bound, that may benefit from targeting with pH/Ca2+-dependent antibodies to obtain increased serum exposure.